blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2437733

EP2437733 - SUSTAINED RELEASE DOSAGE FORM [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.05.2017
Database last updated on 11.09.2024
FormerGrant of patent is intended
Status updated on  23.01.2017
Most recent event   Tooltip19.05.2017Application deemed to be withdrawnpublished on 21.06.2017  [2017/25]
Applicant(s)For all designated states
Dow Global Technologies LLC
2040 Dow Center
Midland, MI 48674 / US
[2012/15]
Inventor(s)01 / ZHAI, Dayu
35-501
No.2878 Gaoqing Road
Shanghai 200124 / CN
02 / GAN, Yong
10-1702
No.88 East Jin An Rd.
Shanghai 201204 / CN
03 / SCHMITT, Robert, L.
40 Regional Road
Annandale New Jersey 08801 / US
04 / ZHU, Chunliu
7-302
2373 Long Hua Road
Shanghai 200030 / CN
05 / CHAN, Alan, Ka Chun
5413 Tyler Street
Midland Michigan 48642 / US
 [2012/15]
Representative(s)f & e patent
Braunsberger Feld 29
51429 Bergisch Gladbach / DE
[N/P]
Former [2013/22]polypatent BGL
Braunsberger Feld 29
51429 Bergisch Gladbach / DE
Former [2012/15]Fleischer, Holm Herbert, et al
Braunsberger Feld 29
51429 Bergisch Gladbach / DE
Application number, filing date09845392.102.06.2009
WO2009CN72099
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010139111
Date:09.12.2010
Language:EN
[2010/49]
Type: A1 Application with search report 
No.:EP2437733
Date:11.04.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 09.12.2010 takes the place of the publication of the European patent application.
[2012/15]
Search report(s)International search report - published on:CN09.12.2010
(Supplementary) European search report - dispatched on:EP05.12.2013
ClassificationIPC:A61K9/32, A61K9/22, A61K9/50, A61K47/38, A61K47/34, A61K9/00, A61K31/00
[2014/02]
CPC:
A61K9/0004 (EP,US); A61K31/00 (EP,US)
Former IPC [2012/15]A61K9/32, A61K9/22, A61K9/50, A61K47/38, A61K47/34
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/15]
TitleGerman:RETARD-DARREICHUNGSFORM[2012/15]
English:SUSTAINED RELEASE DOSAGE FORM[2012/15]
French:FORME POSOLOGIQUE À LIBÉRATION PROLONGÉE[2012/15]
Entry into regional phase22.12.2011National basic fee paid 
22.12.2011Search fee paid 
22.12.2011Designation fee(s) paid 
22.12.2011Examination fee paid 
Examination procedure01.04.2011Request for preliminary examination filed
International Preliminary Examining Authority: CN
22.12.2011Examination requested  [2012/15]
05.05.2014Amendment by applicant (claims and/or description)
24.09.2014Despatch of a communication from the examining division (Time limit: M04)
09.01.2015Reply to a communication from the examining division
03.08.2016Communication of intention to grant the patent
14.12.2016Application deemed to be withdrawn, date of legal effect  [2017/25]
24.01.2017Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2017/25]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.09.2014
Fees paidRenewal fee
14.11.2011Renewal fee patent year 03
14.06.2012Renewal fee patent year 04
10.06.2013Renewal fee patent year 05
31.03.2014Renewal fee patent year 06
10.06.2015Renewal fee patent year 07
10.06.2016Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP0347024  (ALZA CORP [US]) [X] 1-12 * examples 1-3 *;
 [X]WO2006123364  (SUN PHARMACEUTICAL IND LTD [IN]; DHARMADHIKARI NITIN BHALACHAND [IN];) [X] 1-12 * examples 1-3 *;
 [E]EP2085078  (COSCI MED TECH CO LTD [CN]) [E] 1-12 * example 2 *;
 [X]WO2008052417  (COSCI MED TECH CO LTD [CN]; WANG JINGANG [CN]; JIANG HAISONG [CN]) [X] 1-12 * example 2 *;
 [XI]WO02062299  (ANDRX PHARMACEUTICALS INC [US]) [X] 1 * examples 1,3 * [I] 2-12;
 [I]  - VERMA R K ET AL, "Formulation aspects in the development of osmotically controlled oral drug delivery systems", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, (20020219), vol. 79, no. 1-3, doi:10.1016/S0168-3659(01)00550-8, ISSN 0168-3659, pages 7 - 27, XP004340909 [I] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0168-3659(01)00550-8
 [I]  - FLORENCE LECOMTE ET AL, "pH-Sensitive Polymer Blends used as Coating Materials to Control Drug Release from Spherical Beads: Importance of the Type of Core", BIOMACROMOLECULES, (20050701), vol. 6, no. 4, doi:10.1021/bm0500704, ISSN 1525-7797, pages 2074 - 2083, XP055031840 [I] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.1021/bm0500704
International search[X]CN101146521  (SUN PHARM IND LTD.);
 [X]CN1074603  (BAYERAG);
 [A]CN1923184  (BEIJING KEXIN BICHENG SCI & TECH DEV CO.);
 [A]US6485748  (ANDRX PHARMACEUTICALS, INC.);
 [A]WO02062299  (ANDRX PHARMACEUTICALS, INC.)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.